PHILADELPHIA, June 25, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing ...

Find the latest GUANGSHEN RAIL (0525.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.

CT-0525 is the first CAR-Monocyte to be evaluated in humans in the solid tumor setting First patient expected to be treated in the first half of 2024 "CT-0525 is the first CAR-Monocyte to be evaluated ...

Guangshen Railway (0525) has delivered a 4.780% change over the past year, with a 52-week range between 1.570 and 2.640. What Is the Average Daily Trading Volume of Guangshen Railway (0525)? The ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.